RPL35A

Large ribosomal subunit protein eL33 · P18077 · RPL35A on Sugi Atlas →

3,677 patent compounds predicted against RPL35A, 1,927 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL5500526	0.41	4/20
SCHEMBL5500532	0.41	4/20
SCHEMBL5503310	0.41	4/20
SCHEMBL11844361	0.35	4/20
SCHEMBL2000440	0.39	3/20
SCHEMBL8219903	0.36	3/20
SCHEMBL11627320	0.34	3/20
SCHEMBL10271044	0.55	2/20
SCHEMBL6394396	0.47	2/20
N-Methylpiperidine (SCHEMBL11205373)	0.42	2/20
Bicarbonate (SCHEMBL9058396)	0.42	2/20
SCHEMBL4960293	0.41	2/20
SCHEMBL4961968	0.40	2/20
SCHEMBL6686992	0.40	2/20
SCHEMBL9429122	0.38	2/20
Chloramphenicol (SCHEMBL10796001)	1.00	1/20
Geneticin (SCHEMBL15596)	0.93	1/20
Geneticin (SCHEMBL5006573)	0.93	1/20
Geneticin (SCHEMBL9920496)	0.93	1/20
Chloramphenicol (SCHEMBL16111)	0.90	1/20

Clinical trials — most relevant to RPL35A by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes	PHASE4	UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients	PHASE2	COMPLETED
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma	PHASE2	COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension	PHASE1/PHASE2	RECRUITING
Everolimus for Children With Recurrent or Progressive Ependymoma	PHASE2	COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS	PHASE2	COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma	PHASE1	COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors	PHASE1	COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors	PHASE1	COMPLETED
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors	PHASE1	COMPLETED
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus	nan	COMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma	nan	COMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages	nan	COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors	nan	COMPLETED
Quantification of GADD34 Expression in RA	nan	COMPLETED
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants	nan	COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia	nan	NOT_YET_RECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas	nan	ACTIVE_NOT_RECRUITING
Proteomics and Orthodontic Root Resorption	nan	COMPLETED
The Partners Genetics Collaborative Study of Schizophrenia	nan	COMPLETED
miR-155 Expression in Episodic and Chronic Migraine	nan	UNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics	nan	UNKNOWN
Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type	nan	UNKNOWN
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
RibOSE - Glucose and Resistance Exercise Training	nan	COMPLETED
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma	nan	WITHDRAWN

Related proteins — ESM-2 sequence neighbours (a RPL35A binder may also engage these)

Protein	Name	Similarity
O55142	—	1.000	O55142 →
P02434	—	1.000	P02434 →
Q5R8K6	—	1.000	Q5R8K6 →
P61272	—	1.000	P61272 →
Q9FZH0	—	1.000	Q9FZH0 →
P51422	—	1.000	P51422 →
Q56JY1	—	1.000	Q56JY1 →
P04646	—	1.000	P04646 →
P05744	—	1.000	P05744 →
G1SF08	—	0.999	G1SF08 →
A0A1D8PHH4	—	0.998	A0A1D8PHH4 →
P49180	—	0.998	P49180 →
Q9USX4	—	0.997	Q9USX4 →
P41056	—	0.997	P41056 →
Q90YT3	—	0.996	Q90YT3 →
Q55BN7	—	0.994	Q55BN7 →
Q9C912	—	0.994	Q9C912 →
P0DJ22	—	0.987	P0DJ22 →
Q9USG6	—	0.987	Q9USG6 →
B0SSI2	—	0.986	B0SSI2 →
B0SAF9	—	0.986	B0SAF9 →
Q9LMK0	—	0.986	Q9LMK0 →
B8ZSC4	—	0.984	B8ZSC4 →
A1ALT6	—	0.984	A1ALT6 →
A6LLK8	—	0.984	A6LLK8 →
A9BHB0	—	0.984	A9BHB0 →
B7JUP8	—	0.983	B7JUP8 →
Q8KNX8	—	0.983	Q8KNX8 →
A4QJM3	—	0.983	A4QJM3 →
A4QLD0	—	0.983	A4QLD0 →